RxDoctor Payments DataLook up a doctor →

Jason Slakter, MD

Ophthalmology · New York, NYNPI 1275562084

Payments from drug & device makers

$1,227,746in general payments, 2019–2025

Across 80 payments — averaging $15,347 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$467K
  • Mylan Technologies Inc.$429K
  • Aerie Pharmaceuticals, Inc.$229K
  • F. Hoffmann-la Roche AG$40K
  • Alcon$26K
  • Mylan Inc.$20K
  • plus $18K from 7 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,227,746 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.

See all ophthalmology providers in New York

Medicare billing

Part B allowed, 2024
$1,619,058
Medicare patients
375
Services billed
25,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →